Newest Wholesome Youngsters Information
WEDNESDAY, March 30, 2022 (HealthDay Information)
Some youngsters get MIS-C — shorthand for multisystem inflammatory syndrome in kids — 4 to 6 weeks after a bout with COVID. Many have few or no COVID signs, however then develop signs of MIS-C, which embody fever, stomach upset, rash and red eyes.
Whereas MIS-C might be deadly, it’s treatable with steroids or immune-globulin infusion if identified early.
“As a result of so little is thought concerning the causes of MIS-C in kids beforehand contaminated with COVID, many well being care suppliers and oldsters feared that kids with a historical past of MIS-C could redevelop MIS-C or an analogous inflammatory drawback from the vaccination,” examine senior creator Dr. Tiphanie Vogel mentioned in a information launch from Baylor School of Drugs in Houston.
“However our multidisciplinary strategy to learning this concern led us to suggest that these sufferers with a historical past of MIS-C nonetheless get vaccinated to guard themselves from reinfection,” mentioned Vogel. She’s an assistant professor of pediatrics on the medical college and a researcher on the affiliated Texas Youngsters’s Hospital.
This study included 15 youths, ages 12 to 18, who recovered from MIS-C and acquired the Pfizer vaccine at the very least 90 days after their prognosis of MIS-C. They had been adopted for 9.5 months after vaccination.
All contributors tolerated the vaccine with solely gentle uncomfortable side effects much like these seen within the basic inhabitants, the examine discovered.
The findings had been revealed March 28 in JAMA Network Open.
Researchers are persevering with to observe kids within the examine, in addition to a bunch of these beneath 12 years of age who acquired the COVID-19 vaccine after recovering from MIS-C.
The examine researchers acquired funding from Pfizer, a COVID vaccine producer, and Gilead, developer of an antiviral remedy for the illness.
There’s extra on MIS-C on the U.S. Centers for Disease Control and Prevention.
SOURCE: Baylor School of Drugs, information launch, March 28, 2022
By Robert Preidt HealthDay Reporter
Copyright © 2021 HealthDay. All rights reserved.